Ensorcell published an insight article examining cross-contamination risk in multiproduct manufacturing, the role of single-use technologies, and sterile tube welding in bioprocess workflows.
Published
Signal category
Research & Knowledge
Quote
“In our latest insight, we take a closer look at cross-contamination risk in multiproduct manufacturing, the role of single-use technologies and why sterile tube welding remains an important consideration in modern bioprocess workflows.”
— Ensorcell team
Company
Ensorcell
Empowering life scientists with tools that accelerate the journey from research to commercialization.
- Industry
- Biotechnology Research
- Location
- Framingham, US
- Company size
- 8 employees
At Ensorcell we are captivated by the impact of science on life, which is why we started a company to reimagine critical process tools. We identify process tools that can be optimized in a flexible, portable format that is easy to maintain, and commercialize these tools with our Superb Value mindset. Our team has the ability to operate with a startup mentality of breaking barriers, while being supported by access to a vast network of Re:Build Manufacturing resources that allow us to rapidly reimagine life science tools that help to advance therapeutic progress.
Founded 2025